Zura Bio Limited (94E.F)
EUR 0.98
(-7.55%)
EUR 0.98
(-7.55%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 100.84 Million USD | 1816.44% |
| 2022 | 5.26 Million USD | 11.48% |
| 2021 | 4.72 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 90.48 Million USD | -10.27% |
| 2024 Q2 | 189.5 Million USD | 109.43% |
| 2023 Q2 | 113.33 Million USD | 155.34% |
| 2023 Q4 | 100.84 Million USD | -3.58% |
| 2023 FY | 100.84 Million USD | 1816.44% |
| 2023 Q1 | 44.38 Million USD | 0.0% |
| 2023 Q3 | 104.59 Million USD | -7.71% |
| 2022 Q1 | 4.72 Million USD | 0.0% |
| 2022 FY | 5.26 Million USD | 11.48% |
| 2022 Q3 | 5.17 Million USD | -7.33% |
| 2022 Q2 | 5.58 Million USD | 18.22% |
| 2021 FY | 4.72 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| BioNTech SE | 23 Billion EUR | 99.562% |
| CureVac N.V. | 788.89 Million EUR | 87.217% |
| Biotest Aktiengesellschaft | 1.44 Billion EUR | 93.018% |
| Biotest Aktiengesellschaft | 1.44 Billion EUR | 93.018% |
| BRAIN Biotech AG | 70.93 Million EUR | -42.159% |
| Formycon AG | 890.36 Million EUR | 88.674% |
| Heidelberg Pharma AG | 70.35 Million EUR | -43.339% |
| Medigene AG | 31.71 Million EUR | -217.956% |